EverSource Wealth Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04K Buy
1,051
+801
+320% +$3.28K ﹤0.01% 3358
2025
Q4
$927 Buy
250
+206
+468% +$1.77K ﹤0.01% 3726
2025
Q3
$621 Buy
+44
New +$686 ﹤0.01% 3891
2024
Q3
Sell
-16
Closed -$852 3094
2024
Q2
$852 Buy
16
+1
+7% +$49 ﹤0.01% 2771
2024
Q1
$567 Hold
15
﹤0.01% 2685
2023
Q4
$1.21K Buy
+15
New +$1.22K ﹤0.01% 2334

Other funds holding OM

EverSource Wealth Advisors's OM Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Outset Medical (OM) stake by 320% in Q1 2026, buying an estimated $3.28K and bringing the position to 1,051 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3358.

EverSource Wealth Advisors first reported a position in OM in Q4 2023 and has held it in 6 quarters since. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • EverSource Wealth Advisors held 1,051 shares of Outset Medical worth $4.04K as of Q1 2026.
  • EverSource Wealth Advisors bought 801 Outset Medical shares in Q1 2026, an estimated $3.28K.
  • Outset Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3358 holding.
  • EverSource Wealth Advisors first reported a position in Outset Medical in Q4 2023 and has held it in 6 quarters since.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.